Barry Gidal

Barry Gidal

University of Wisconsin Madison - Madison / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1878799
person_outline Barry Gidal's MOST POPULAR ARTICLES
1-) Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality …CL Harden, KJ Meador, PB Pennell, WA Hauser, GS Gronseth, JA French, ...Neurology 73 (2), 133-141, 2009672*2009
2-) Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee and …JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ...Neurology 62 (8), 1252-1260, 20046122004
3-) Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee and …JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ...Neurology 62 (8), 1252-1260, 20046162004
4-) Enzyme induction with antiepileptic drugs: cause for concern?MJ Brodie, S Mintzer, AM Pack, BE Gidal, CJ Vecht, D SchmidtEpilepsia 54 (1), 11-27, 20134292013
5-) A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly …L Taylor, B Gidal, G Blakey, B Tayo, G MorrisonCNS drugs 32, 1053-1067, 20184222018